Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Editorial Commentary: When should the patient with an inherited cardiac disease have an ICD?

Publikation: Bidrag til tidsskriftLederpeer review

DOI

  1. Symptoms and healthcare contact preceding sudden cardiac death in persons aged 1-49 years

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. An overview of current and emerging devices for percutaneous left atrial appendage closure

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Glucagon-like peptide 1--a cardiologic dimension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Witnessed and unwitnessed sudden cardiac death: a nationwide study of persons aged 1-35 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Detection of atrial fibrillation with implantable loop recorders in horses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Familial Evaluation in Idiopathic Ventricular Fibrillation: Diagnostic Yield and Significance of J-Wave Syndromes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Symptoms Preceding Sports-Related Sudden Cardiac Death in Persons Aged 1-49 Years

    Publikation: Bidrag til tidsskriftReviewpeer review

Vis graf over relationer

The implantable cardioverter defibrillator (ICD) is often considered a routine intervention for an inherited heart rhythm disorder (IHRD) despite there being little to no randomized data for non-ischemic indications. Furthermore, existing IHRD studies often do not report adverse ICD outcomes, and observational data increasingly show that complications are under-recognized. Only recently have tools emerged to address the rational use of ICDs for specific forms of IHRD, although the acceptable risk of device complications remains unestablished. Here, we summarize the evidence of ICD benefit and harm in IHRD, highlight current knowledge gaps, and propose alternative and adjunctive options to the transvenous ICD.

OriginalsprogEngelsk
TidsskriftTrends in Cardiovascular Medicine
Vol/bind30
Udgave nummer7
Sider (fra-til)422-423
Antal sider2
ISSN1050-1738
DOI
StatusUdgivet - okt. 2020

Bibliografisk note

Copyright © 2019 Elsevier Inc. All rights reserved.

ID: 59483929